- Home
- VICR vs BCRX Comparison
VICR vs BCRX Comparison
Compare VICR & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VICR
- BCRX
- Stock Information
- Founded
- VICR 1981
- BCRX 1986
- Country
- VICR United States
- BCRX United States
- Employees
- VICR N/A
- BCRX N/A
- Industry
- VICR Industrial Machinery/Components
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VICR Technology
- BCRX Health Care
- Exchange
- VICR Nasdaq
- BCRX Nasdaq
- Market Cap
- VICR 1.9B
- BCRX 1.9B
- IPO Year
- VICR N/A
- BCRX 1994
- Fundamental
- Price
- VICR $45.20
- BCRX $8.64
- Analyst Decision
- VICR Hold
- BCRX Strong Buy
- Analyst Count
- VICR 2
- BCRX 10
- Target Price
- VICR $43.00
- BCRX $16.70
- AVG Volume (30 Days)
- VICR 273.5K
- BCRX 3.2M
- Earning Date
- VICR 07-22-2025
- BCRX 08-04-2025
- Dividend Yield
- VICR N/A
- BCRX N/A
- EPS Growth
- VICR N/A
- BCRX N/A
- EPS
- VICR 0.51
- BCRX N/A
- Revenue
- VICR $369,154,000.00
- BCRX $503,485,000.00
- Revenue This Year
- VICR $14.66
- BCRX $38.50
- Revenue Next Year
- VICR $15.24
- BCRX $10.04
- P/E Ratio
- VICR $88.07
- BCRX N/A
- Revenue Growth
- VICR N/A
- BCRX 41.67
- 52 Week Low
- VICR $34.27
- BCRX $6.02
- 52 Week High
- VICR $65.70
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- VICR 45.93
- BCRX 31.39
- Support Level
- VICR $47.38
- BCRX $8.45
- Resistance Level
- VICR $49.03
- BCRX $8.79
- Average True Range (ATR)
- VICR 1.43
- BCRX 0.24
- MACD
- VICR -0.04
- BCRX -0.02
- Stochastic Oscillator
- VICR 28.41
- BCRX 0.00
About VICR Vicor Corporation
Vicor Corp manufactures and markets modular power components and complete power systems for converting electrical power. It provides modular power converters and configurable products, power component products and integrated circuits, and related products. Its products include Converters, Power Systems, Filters, Custom Power Systems, Input Modules, and others.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.